Intrathecal Duros Opioid Delivery Using a Precision Miniature Catheter

To deliver drug to a specific target site, DURECT company developed a proprietary miniaturized catheter technology that can be attached to the DUROS® system to direct the flow of drug directly to the target organ within the spinal cord. Undergoing preclinical evaluation, this site-specific delivery enables a therapeutic concentration of a drug to be present at the desired target opioid receptor sites without exposing the entire body of the patient to a similar dose. The precision, miniature size, and performance characteristics of the DUROS® system allows continuous site-specific delivery, using DUROS® with a miniature catheter are presented (Fig. IV-43).

The precision DUROS® Intrathecal Opioid Delivery System is indicated for a number of chronic pain conditions, which include chronic back and leg pain, chronic cancer pain, complex regional pain syndromes (usually in the foot or

Figure IV-43. The DUROS® opioid intrathecal delivery system hand), and painful neuropathy. By directly delivering opioids, such as morphine or hydromorphone, into the intrathecal space surrounding the spinal cord using the DUROS® system, significantly smaller doses of the drug are required to elicit pain relief. A DUROS® Intrathecal (opioid) delivery system presently is at the preclinical stage.

The figure illustrates the DUROS® intrathecal (opioid) delivery system with a catheter, which is surgically implanted subcutaneously near the target-site of drug administration. The proprietary miniature catheter is attached to the DUROS® system and tunneled under the skin to the site where opioid is to be delivered. The DUROS® system is designed to deliver the drug at a constant, preset rate through the catheter to the targeted intrathecal site for a prescribed duration of approximately 3 months. The proprietary catheter has a hold-up volume of about 20 ju,l.

DUROS® Intrathecal Opioid Delivery System has a nominal volume-pumping rate of 10 ^l/day (0.42 ^l/h). The following figure demonstrates a constant volume-pumping rate from a DUROS® system over 100 days. The in vitro pumping rate was determined by placing the systems in an aqueous buffer solution at 37 °C, and by measuring the effluent from the systems at preset time intervals. Both the initial start-up time and completion of systems pumping action are predictable and reproducible between different systems (Fig. IV-44). By varying the drug concentration in the reservoir, the opioid can be intrathecally administered at the rate from 10 to 100 ^g/h.



\ '

1 1

1 1

Figure IV-44. In vitro release rate from the DUROS® opioid intrathecal delivery system

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment